PainReform Ltd (NASDAQ:PRFX) announced results from new studies demonstrating the superior in-vitro release (IVR) rates of PRF-110 compared to topical post-surgical pain management products available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback